• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Methylphenidate transdermal system in attention-deficit hyperactivity disorder in adolescents: profile report.

作者信息

Keating Gillian M

机构信息

Adis, Auckland, New Zealand.

出版信息

Drugs R D. 2012 Sep 1;12(3):171-3. doi: 10.2165/11207490-000000000-00000.

DOI:10.2165/11207490-000000000-00000
PMID:22934753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3585903/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee3f/4239252/ff0bc08cc9ad/40268_2012_12030171_Tab1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee3f/4239252/ff0bc08cc9ad/40268_2012_12030171_Tab1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee3f/4239252/ff0bc08cc9ad/40268_2012_12030171_Tab1.jpg

相似文献

1
Methylphenidate transdermal system in attention-deficit hyperactivity disorder in adolescents: profile report.青少年注意力缺陷多动障碍中哌甲酯透皮系统：概述报告
Drugs R D. 2012 Sep 1;12(3):171-3. doi: 10.2165/11207490-000000000-00000.
2
Methylphenidate transdermal system: in attention-deficit hyperactivity disorder in adolescents.哌醋甲酯透皮贴剂：治疗青少年注意缺陷多动障碍。
CNS Drugs. 2011 Apr;25(4):333-42. doi: 10.2165/11206730-000000000-00000.
3
A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder.一项关于哌甲酯透皮系统治疗小儿注意力缺陷/多动障碍的随机、双盲、安慰剂对照平行组研究。
J Clin Psychiatry. 2008 Jan;69(1):149-59. doi: 10.4088/jcp.v69n0120.
4
Chemical leukoderma after the application of a transdermal methylphenidate patch.
J Am Acad Dermatol. 2012 Jun;66(6):e237-8. doi: 10.1016/j.jaad.2011.03.030.
5
Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder.改变哌甲酯透皮系统在注意缺陷多动障碍儿童中的佩戴时间。
J Am Acad Child Adolesc Psychiatry. 2008 Jun;47(6):700-708. doi: 10.1097/CHI.0b013e31816bffdf.
6
Methylphenidate transdermal system in attention-deficit hyperactivity disorder in children: A viewpoint by Raul R. Silva.儿童注意力缺陷多动障碍中的哌甲酯透皮系统：劳尔·R·席尔瓦的观点
Drugs. 2006;66(8):1127-8; discussion 1128. doi: 10.2165/00003495-200666080-00008.
7
Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.随机对照双盲试验研究最佳剂量哌醋甲酯治疗伴有严重注意缺陷多动障碍和智力障碍的儿童和青少年。
J Child Psychol Psychiatry. 2013 May;54(5):527-35. doi: 10.1111/j.1469-7610.2012.02569.x. Epub 2012 Jun 7.
8
Effects of methylphenidate on cardiovascular responses in attention deficit hyperactivity disordered adolescents.哌甲酯对注意力缺陷多动障碍青少年心血管反应的影响。
J Adolesc Health Care. 1989 May;10(3):179-83. doi: 10.1016/0197-0070(89)90229-5.
9
Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.每日一次的渗透泵型哌甲酯对患有注意力缺陷/多动障碍的青少年来说是安全且耐受性良好的。
J Child Adolesc Psychopharmacol. 2006 Jun;16(3):351-6. doi: 10.1089/cap.2006.16.351.
10
Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.安非他酮与哌甲酯治疗儿童注意力缺陷/多动障碍的随机双盲研究
Hum Psychopharmacol. 2012 Jul;27(4):411-8. doi: 10.1002/hup.2242.

引用本文的文献

1
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍（ADHD）儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
2
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍（ADHD）的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
3
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

本文引用的文献

1
Methylphenidate transdermal system: in attention-deficit hyperactivity disorder in adolescents.哌醋甲酯透皮贴剂：治疗青少年注意缺陷多动障碍。
CNS Drugs. 2011 Apr;25(4):333-42. doi: 10.2165/11206730-000000000-00000.
2
A 6-month, open-label, extension study of the tolerability and effectiveness of the methylphenidate transdermal system in adolescents diagnosed with attention-deficit/hyperactivity disorder.一项关于哌甲酯透皮系统治疗被诊断为注意力缺陷/多动障碍青少年的耐受性和有效性的为期6个月的开放标签扩展研究。
J Child Adolesc Psychopharmacol. 2010 Oct;20(5):365-75. doi: 10.1089/cap.2009.0122.
3
A randomized, double-blind, multicenter, parallel-group, placebo-controlled, dose-optimization study of the methylphenidate transdermal system for the treatment of ADHD in adolescents.
用于治疗儿童和青少年注意力缺陷多动障碍（ADHD）的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
一项关于哌醋甲酯透皮系统治疗青少年注意缺陷多动障碍的随机、双盲、多中心、平行分组、安慰剂对照、剂量优化研究。
CNS Spectr. 2010 Jul;15(7):419-30. doi: 10.1017/s1092852900000353.
4
Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder.改变哌甲酯透皮系统在注意缺陷多动障碍儿童中的佩戴时间。
J Am Acad Child Adolesc Psychiatry. 2008 Jun;47(6):700-708. doi: 10.1097/CHI.0b013e31816bffdf.
5
Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.注意缺陷/多动障碍儿童和青少年评估与治疗的实践参数
J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):894-921. doi: 10.1097/chi.0b013e318054e724.
6
Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children.哌甲酯透皮系统：用于儿童注意力缺陷多动障碍。
Drugs. 2006;66(8):1117-26. doi: 10.2165/00003495-200666080-00007.
7
Attention-deficit/hyperactivity disorder: a selective overview.注意力缺陷多动障碍：选择性概述。
Biol Psychiatry. 2005 Jun 1;57(11):1215-20. doi: 10.1016/j.biopsych.2004.10.020. Epub 2004 Dec 18.
8
Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study.注意缺陷多动障碍持续至青春期及缓解的预测因素：一项为期四年的前瞻性随访研究结果
J Am Acad Child Adolesc Psychiatry. 1996 Mar;35(3):343-51. doi: 10.1097/00004583-199603000-00016.